BUZZ-Ionis Pharma up after unveiling $700 mln convertible bonds offering

Reuters

Nov 12, 2025

** Shares of Ionis Pharmaceuticals IONS.O up 1.5% at $73.50 as co seeks capital raise to refinance debt

** Carlsbad, California-based firm announces private offering of $700 mln convertible bonds (CBs) due 2030

** Co plans to use net offering proceeds to repurchase/repay its 2026 0% CBs, any remainder for general corp purposes

** Drug developer for neurological and cardiometabolic diseases has about 162 mln shares outstanding for roughly $11.7 bln market cap

** IONS ended up 4.2% at $72.45 on Tues, up 107% YTD

** Of 24 analysts covering IONS, recommendation breakdown is 18 "strong buy" or "buy", 6 "hold", per LSEG

** Median PT of $83 up from $78 a month ago and $62 on Aug 11

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2582180743"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582180743\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582180743?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 06:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582180743","market":"us","top_or_hot":-1,"title":"BUZZ-Ionis Pharma up after unveiling $700 mln convertible bonds offering","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Ionis Pharma up after unveiling $700 mln convertible bonds offering </title></head><body><p>** Shares of Ionis Pharmaceuticals <span>IONS.O</span> up 1.5% at $73.50 as co seeks capital raise to refinance debt</p><p>** Carlsbad, California-based firm announces private offering of $700 mln convertible bonds (CBs) due 2030</p><p>** Co plans to use net offering proceeds to repurchase/repay its 2026 0% CBs, any remainder for general corp purposes</p><p>** Drug developer for neurological and cardiometabolic diseases has about 162 mln shares outstanding for roughly $11.7 bln market cap</p><p>** IONS ended up 4.2% at $72.45 on Tues, up 107% YTD</p><p>** Of 24 analysts covering IONS, recommendation breakdown is 18 \"strong buy\" or \"buy\", 6 \"hold\", per LSEG</p><p>** Median PT of $83 up from $78 a month ago and $62 on Aug 11</p><p>(Lance Tupper is a Reuters market analyst. The views expressed are his own)</p><p>((lance.tupper@tr.com 1-646-279-6380))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Ionis Pharma up after unveiling $700 mln convertible bonds offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Ionis Pharma up after unveiling $700 mln convertible bonds offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-12 06:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Ionis Pharma up after unveiling $700 mln convertible bonds offering </title></head><body><p>** Shares of Ionis Pharmaceuticals <span>IONS.O</span> up 1.5% at $73.50 as co seeks capital raise to refinance debt</p><p>** Carlsbad, California-based firm announces private offering of $700 mln convertible bonds (CBs) due 2030</p><p>** Co plans to use net offering proceeds to repurchase/repay its 2026 0% CBs, any remainder for general corp purposes</p><p>** Drug developer for neurological and cardiometabolic diseases has about 162 mln shares outstanding for roughly $11.7 bln market cap</p><p>** IONS ended up 4.2% at $72.45 on Tues, up 107% YTD</p><p>** Of 24 analysts covering IONS, recommendation breakdown is 18 \"strong buy\" or \"buy\", 6 \"hold\", per LSEG</p><p>** Median PT of $83 up from $78 a month ago and $62 on Aug 11</p><p>(Lance Tupper is a Reuters market analyst. The views expressed are his own)</p><p>((lance.tupper@tr.com 1-646-279-6380))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nL6N3WN11L:1","article_id":"2582180743","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582180743","pubTimestamp":1762900034,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Ionis Pharma up after unveiling $700 mln convertible bonds offering** Shares of Ionis Pharmaceuticals IONS.O up 1.5% at $73.50 as co seeks capital raise to refinance debt** Carlsbad, California-based firm announces private offering of $700 mln convertible bonds  due 2030** Co plans to use net offering proceeds to repurchase/repay its 2026 0% CBs, any remainder for general corp purposes** Drug developer for neurological and cardiometabolic diseases has about 162 mln shares outstanding for roughly $11.7 bln market cap** IONS ended up 4.2% at $72.45 on Tues, up 107% YTD** Of 24 analysts covering IONS, recommendation breakdown is 18 \"strong buy\" or \"buy\", 6 \"hold\", per LSEG** Median PT of $83 up from $78 a month ago and $62 on Aug 11","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","IONS":"Ionis Pharmaceuticals, Inc"},"translate_title":"BUZZ-Ionis Pharma在推出7亿美元可转换债券发行后上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IONS":0.9},"content_text":"BUZZ-Ionis Pharma up after unveiling $700 mln convertible bonds offering ** Shares of Ionis Pharmaceuticals IONS.O up 1.5% at $73.50 as co seeks capital raise to refinance debt** Carlsbad, California-based firm announces private offering of $700 mln convertible bonds (CBs) due 2030** Co plans to use net offering proceeds to repurchase/repay its 2026 0% CBs, any remainder for general corp purposes** Drug developer for neurological and cardiometabolic diseases has about 162 mln shares outstanding for roughly $11.7 bln market cap** IONS ended up 4.2% at $72.45 on Tues, up 107% YTD** Of 24 analysts covering IONS, recommendation breakdown is 18 \"strong buy\" or \"buy\", 6 \"hold\", per LSEG** Median PT of $83 up from $78 a month ago and $62 on Aug 11(Lance Tupper is a Reuters market analyst. The views expressed are his own)((lance.tupper@tr.com 1-646-279-6380))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}